Literature DB >> 15880615

Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer.

Brenda B J Hermsen1, Silvia von Mensdorff-Pouilly, Hans F J Fabry, Hay A H Winters, Peter Kenemans, René H M Verheijen, Paul J van Diest.   

Abstract

The aim of this study was to investigate closely the nature of premalignant lesions that occur in prophylactically removed breast tissue from patients at hereditary high risk of breast cancer. Breast tissues obtained from 41 patients who underwent prophylactic mastectomy (pM) because of a hereditary high risk of breast cancer and control tissues from 82 age-matched healthy controls who underwent breast reduction surgery were screened for premalignant lesions. Premalignant and malignant lesions were more frequent (p = 0.0016) in pM samples (5/41) than in controls (1/82). Interestingly, lobulitis, defined as more than 100 lymphocytes and/or plasma cells per lobule in more than one section in morphologically normal lobules, was encountered in 21 of 41 (51%) pM patients, in contrast to only 8 of 82 (10%) controls (p < 0.0001). Preliminary observations indicate a predominance of T-cells in these infiltrates, in agreement with the already known frequent presence of lymphocytic infiltration in hereditary ductal in situ and infiltrating ductal/medullary carcinomas. This novel finding implies an immune reaction to an as yet unidentified antigen frequently present in women at hereditary high risk of breast cancer, possibly as part of an early carcinogenic event. Copyright 2005 Pathological Society of Great Britain and Ireland

Entities:  

Mesh:

Year:  2005        PMID: 15880615     DOI: 10.1002/path.1774

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  11 in total

1.  Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations.

Authors:  M R Hussein; H I Hassan
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

Review 2.  Pathology of hereditary breast cancer.

Authors:  Petra van der Groep; Elsken van der Wall; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2011-02-19       Impact factor: 6.730

3.  Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers.

Authors:  Randal L Croshaw; Megan L Marshall; Tesha L Williams; Kathleen M Erb; Thomas B Julian
Journal:  Int J Breast Cancer       Date:  2011-09-04

Review 4.  Mutations in components of antiviral or microbial defense as a basis for breast cancer.

Authors:  Bernard Friedenson
Journal:  Funct Integr Genomics       Date:  2013-09-21       Impact factor: 3.674

5.  Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.

Authors:  Anne Grote; Mahmoud Abbas; Nina Linder; Hans H Kreipe; Johan Lundin; Friedrich Feuerhake
Journal:  Diagn Pathol       Date:  2014-12-19       Impact factor: 2.644

6.  Hematologic Malignancies of the Breast: A Contemporary Series Investigating Incidence, Presentation, Accuracy of Diagnosis on Core Needle Biopsy, and Hormone Receptor Expression.

Authors:  Marie-Christine Guilbert; Jason L Hornick; Sona A Chikarmane; Susan C Lester
Journal:  Breast Cancer (Auckl)       Date:  2019-02-21

7.  Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.

Authors:  Soley Bayraktar; Hongming Qiu; Diane Liu; Yu Shen; Angelica M Gutierrez-Barrera; Banu K Arun; Aysegul A Sahin
Journal:  Biomark Cancer       Date:  2015-08-18

8.  Immune cell quantitation in normal breast tissue lobules with and without lobulitis.

Authors:  Amy C Degnim; Rushin D Brahmbhatt; Derek C Radisky; Tanya L Hoskin; Melody Stallings-Mann; Mark Laudenschlager; Aaron Mansfield; Marlene H Frost; Linda Murphy; Keith Knutson; Daniel W Visscher
Journal:  Breast Cancer Res Treat       Date:  2014-03-05       Impact factor: 4.872

9.  In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium.

Authors:  J C L Alfonso; N S Schaadt; R Schönmeyer; N Brieu; G Forestier; C Wemmert; F Feuerhake; H Hatzikirou
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

10.  Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers.

Authors:  Anita Grigoriadis; Patrycja Gazinska; Trupti Pai; Sheeba Irhsad; Yin Wu; Rosemary Millis; Kalnisha Naidoo; Julie Owen; Cheryl E Gillett; Andrew Tutt; Anthonius Cc Coolen; Sarah E Pinder
Journal:  J Pathol Clin Res       Date:  2018-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.